BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 28830131)

  • 1. [Pharmacotherapy in Patients with Chronic Constipation].
    Kim SJ; Park KS
    Korean J Gastroenterol; 2017 Aug; 70(2):64-71. PubMed ID: 28830131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current issues on the treatment of chronic constipation].
    Hong KS; Jung KW; Lee TH; Lee BE; Park SY; Shin JE; Kim SE; Park KS; Choi SC
    Korean J Gastroenterol; 2014 Sep; 64(3):148-53. PubMed ID: 25252863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. $850 Per Bowel Movement?! Hard To Justify That Cost.
    Morrow T
    Manag Care; 2017 Mar; 26(3):36-37. PubMed ID: 28510525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Options in Constipation Management.
    Davis M; Gamier P
    Curr Oncol Rep; 2015 Dec; 17(12):55. PubMed ID: 26449843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel therapies for constipation.
    Thayalasekeran S; Ali H; Tsai HH
    World J Gastroenterol; 2013 Dec; 19(45):8247-51. PubMed ID: 24363515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New drugs for the treatment of constipation].
    Adam B; Liebregts T; Gerken G
    Med Klin (Munich); 2010 Jul; 105(7):475-8. PubMed ID: 20676949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of functional constipation in children and adults.
    Vriesman MH; Koppen IJN; Camilleri M; Di Lorenzo C; Benninga MA
    Nat Rev Gastroenterol Hepatol; 2020 Jan; 17(1):21-39. PubMed ID: 31690829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid-induced constipation.
    Gyawali B; Hayashi N; Tsukuura H; Honda K; Shimokata T; Ando Y
    Scand J Gastroenterol; 2015; 50(11):1331-8. PubMed ID: 26061717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation.
    Chang L; Chey WD; Imdad A; Almario CV; Bharucha AE; Diem S; Greer KB; Hanson B; Harris LA; Ko C; Murad MH; Patel A; Shah ED; Lembo AJ; Sultan S
    Gastroenterology; 2023 Jun; 164(7):1086-1106. PubMed ID: 37211380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease.
    Barboza JL; Okun MS; Moshiree B
    Expert Opin Pharmacother; 2015; 16(16):2449-64. PubMed ID: 26374094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New pharmacological treatment options for chronic constipation.
    Corsetti M; Tack J
    Expert Opin Pharmacother; 2014 May; 15(7):927-41. PubMed ID: 24661106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic constipation: current treatment options.
    Liu LW
    Can J Gastroenterol; 2011 Oct; 25 Suppl B(Suppl B):22B-28B. PubMed ID: 22114754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents.
    Tse Y; Armstrong D; Andrews CN; Bitton A; Bressler B; Marshall J; Liu LW
    Can J Gastroenterol Hepatol; 2017; 2017():8612189. PubMed ID: 28271055
    [No Abstract]   [Full Text] [Related]  

  • 14. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
    Thomas RH; Luthin DR
    Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Some practical questions on chronic stipsis treatment with prucalopride].
    Bellacosa L; Cogliandro R; Cremon C; De Giorgio R; Barbara G; Stanghellini V
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):85-99. PubMed ID: 24632771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lubiprostone on vinca alkaloid-induced constipation in patients with hematological malignancies: a propensity score-matched analysis.
    Kawada K; Ohta T; Fukuda H; Hayashi T; Tanaka K; Imai T; Morita Y; Miyamura M
    Ann Hematol; 2020 Oct; 99(10):2429-2436. PubMed ID: 32839869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation.
    Chang L; Chey WD; Imdad A; Almario CV; Bharucha AE; Diem S; Greer KB; Hanson B; Harris LA; Ko C; Murad MH; Patel A; Shah ED; Lembo AJ; Sultan S
    Am J Gastroenterol; 2023 Jun; 118(6):936-954. PubMed ID: 37204227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United States.
    Huang H; Taylor DC; Carson RT; Sarocco P; Friedman M; Munsell M; Blum SI; Menzin J
    J Med Econ; 2015 Apr; 18(4):283-94. PubMed ID: 25333331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prucalopride (Motegrity) for chronic idiopathic constipation.
    Med Lett Drugs Ther; 2019 Jun; 61(1573):86-88. PubMed ID: 31170120
    [No Abstract]   [Full Text] [Related]  

  • 20. Prucalopride succinate for the treatment of constipation: an update.
    Bassotti G; Gambaccini D; Bellini M
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):291-300. PubMed ID: 26647167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.